US 11241499
Human serum albumin in formulations
granted A61KA61K47/26A61K47/42
Quick answer
US patent 11241499 (Human serum albumin in formulations) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K47/26, A61K47/42, A61K9/0019, A61K9/08